Takara Pays Lynx $3M in Modification of Licensing Agreement

genomeweb
360dx

Takara Pays Lynx $3M in Modification of Licensing Agreement

Aug 05, 2003

NEW YORK, Aug. 5 (GenomeWeb News) - Lynx Therapeutics of Hayward, Calif., said today that Takara Bio of Japan has paid it $3 million in a modification of the two companies' technology licensing agreement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Oxford Biodynamics Posts Flat Revenues for FY 2018
Exosome Diagnostics Suing Former Employee for IP Theft
Fluidigm Commences $55M Public Stock Offering
BiomX Inks IBD Biomarker Deal With Janssen
InterVenn BioSciences Raises $9.4M in Funding
Centogene Inks Drug Discovery, Development Deal With Chiesi

The Scan

Blame the Follicles

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Missed a Few

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

This Week in Cell

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Yep, Couple of Concerns There

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

Main menu